Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

PD-145709: New tyrosine kinase inhibitor from Warner-Lambert

April 5, 1996

SU-101 designated orphan drug

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Protein kinase C modulators in the pipeline at Procyon

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

PPI-149 selected for development

April 5, 1996

Sparta develops new formulations of taxanes

April 5, 1996

Roussel Morishita reports new aromatase inhibitor

April 5, 1996

Boehringer Mannheim synthesizes antitumor anthrapyrazoles

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...